Sign in
4

Changes in Ownership

REGENXBIO Inc. Filed Acc 0001562180-20-005162

Chief Financial Officer sold 14,950 shares at $40.10 ($599,495)

  • Chief Financial Officer acquired 3,259 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Vasista Vittal Chief Financial Officer 2020-07-15 Option exercise +3,259 $13.09 $42,660 209,974 D: show line 1 in the form
Vasista Vittal Chief Financial Officer 2020-07-15 Sale −14,950 $40.10 $599,495 195,024 D: show line 2 in the form
Open-market sales · 14,950 sh · avg $40.10 · $599,495

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Vasista Vittal Chief Financial Officer 2020-07-15 Option exercise · Employee Stock Option (Right to Buy) −3,259 14,115 D: show line 3 in the form
Loading xslF345X03/primarydocument.xml…